Before revision: A 2023 study reported that the existing arthritis drug anakinra blocked IL-1B in elderly mice and returned those cells to a more youthful state.
After revision: rheumatoidA 2023 study reported that the existing arthritis drug anakinra blocked IL-1B in elderly mice and returned those cells to a more youthful state.